  Umbilical cord blood (UBC) can be viewed as the most promising source of stem
cells, in which collection cost is minimal and its benefits are immense. The
cord blood is used to treat malignant and nonmalignant diseases; this is due to
its progenitor characteristics know as stem cells.Its properties of being,
immunologically immature and high plasticity has made it superior to other
sources of stem cells. The stem cells collected from cord blood have neutral
differentiation capabilities which allow medical professionals to produce
functional neural cells from these stem cells.Cord Blood Banking (CBB) is the
storing of the umbilical cord blood which is collected immediately after the
delivery of the baby. Great care and concern are needed for proper storage of
these progenitor cells, hence cord blood banks come into the play, they are of
3 types which are: public, private and direct donation banks.Clinical trials
are still at its very early stages having abundances to still be uncovered but
results were obtained have demonstrated high potential and more scope towards
effective development therapies and treatments for rare disorders.
